150 related articles for article (PubMed ID: 36913047)
1. Occurrence of non-central nervous system cancers during postoperative follow-up of patients who underwent surgery for a WHO grade II glioma: implications for therapeutic management.
Duffau H
J Neurooncol; 2023 Mar; 162(1):237-244. PubMed ID: 36913047
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated With Long-term Survival in Women Who Get Pregnant After Surgery for WHO Grade II Glioma.
Ng S; Duffau H
Neurology; 2022 Jul; 99(1):e89-e97. PubMed ID: 35410899
[TBL] [Abstract][Full Text] [Related]
3. Lack of complete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: a marker of worse prognosis?
Gozé C; Rigau V; Gibert L; Maudelonde T; Duffau H
J Neurooncol; 2009 Jan; 91(1):1-5. PubMed ID: 18726074
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up.
Duffau H
Acta Neurochir (Wien); 2016 Jan; 158(1):51-8. PubMed ID: 26530708
[TBL] [Abstract][Full Text] [Related]
5. Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life.
Blonski M; Taillandier L; Herbet G; Maldonado IL; Beauchesne P; Fabbro M; Campello C; Gozé C; Rigau V; Moritz-Gasser S; Kerr C; Rudà R; Soffietti R; Bauchet L; Duffau H
J Neurooncol; 2012 Jan; 106(2):353-66. PubMed ID: 21785913
[TBL] [Abstract][Full Text] [Related]
6. Occipital WHO grade II gliomas: oncological, surgical and functional considerations.
Viegas C; Moritz-Gasser S; Rigau V; Duffau H
Acta Neurochir (Wien); 2011 Oct; 153(10):1907-17; discussion 1917. PubMed ID: 21842441
[TBL] [Abstract][Full Text] [Related]
7. Management of diffuse low-grade cerebral gliomas.
Prabhu VC; Khaldi A; Barton KP; Melian E; Schneck MJ; Primeau MJ; Lee JM
Neurol Clin; 2010 Nov; 28(4):1037-59. PubMed ID: 20816276
[TBL] [Abstract][Full Text] [Related]
8. Delayed leptomeningeal and subependymal seeding after multiple surgeries for supratentorial diffuse low-grade gliomas in adults.
Alvarez de Eulate-Beramendi S; Rigau V; Taillandier L; Duffau H
J Neurosurg; 2014 Apr; 120(4):833-9. PubMed ID: 24286144
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.
Rudà R; Pellerino A; Pace A; Carapella CM; Dealis C; Caroli M; Faedi M; Bello L; Migliore E; Marchese G; Bertero L; Cassoni P; Soffietti R
J Neurooncol; 2019 Oct; 145(1):115-123. PubMed ID: 31556015
[TBL] [Abstract][Full Text] [Related]
10. Neurosurgical treatment of oligodendroglial tumors in children and adolescents: a single-institution series of 35 consecutive patients.
Lundar T; Due-Tønnessen BJ; Egge A; Scheie D; Stensvold E; Brandal P
J Neurosurg Pediatr; 2013 Sep; 12(3):241-6. PubMed ID: 23870041
[TBL] [Abstract][Full Text] [Related]
11. A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.
Steidl E; Filipski K; Zeiner PS; Wagner M; Fokas E; Forster MT; Ronellenfitsch MW; Divé I; Steinbach JP; Harter PN; Bähr O
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2373-2383. PubMed ID: 33538917
[TBL] [Abstract][Full Text] [Related]
12. Re-operation is a safe and effective therapeutic strategy in recurrent WHO grade II gliomas within eloquent areas.
Martino J; Taillandier L; Moritz-Gasser S; Gatignol P; Duffau H
Acta Neurochir (Wien); 2009 May; 151(5):427-36; discussion 436. PubMed ID: 19337688
[TBL] [Abstract][Full Text] [Related]
13. Nuancing the Limitations of Axonal Plasticity in World Health Organization Grade II Gliomas: White Matter Tracts Compensation Is Driven by Cortical Remodeling.
Duffau H
Neurosurgery; 2023 Oct; 93(4):e85-e91. PubMed ID: 37074040
[TBL] [Abstract][Full Text] [Related]
14. Current knowledge and treatment strategies for grade II gliomas.
Narita Y
Neurol Med Chir (Tokyo); 2013; 53(7):429-37. PubMed ID: 23883553
[TBL] [Abstract][Full Text] [Related]
15. Neurosurgical treatment of pediatric low-grade midbrain tumors: a single consecutive institutional series of 15 patients.
Lundar T; Due-Tønnessen BJ; Egge A; Scheie D; Brandal P; Stensvold E; Due-Tønnessen P
J Neurosurg Pediatr; 2014 Dec; 14(6):598-603. PubMed ID: 25325421
[TBL] [Abstract][Full Text] [Related]
16. [Controversial aspects in WHO grade II gliomas management: review of recent literature].
Rueda E; Sierra M; Infante J; Berciano J; Vázquez-Barquero A; Ciordia R; Martino J
Rev Neurol; 2011 Dec; 53(12):747-57. PubMed ID: 22127662
[TBL] [Abstract][Full Text] [Related]
17. A personal consecutive series of surgically treated 51 cases of insular WHO Grade II glioma: advances and limitations.
Duffau H
J Neurosurg; 2009 Apr; 110(4):696-708. PubMed ID: 19133753
[TBL] [Abstract][Full Text] [Related]
18. Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016.
Compes P; Tabouret E; Etcheverry A; Colin C; Appay R; Cordier N; Mosser J; Chinot O; Delingette H; Girard N; Dufour H; Metellus P; Figarella-Branger D
J Neurooncol; 2019 May; 142(3):511-520. PubMed ID: 30756272
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility of maximal safe resection of WHO grade II gliomas within eloquent areas.
Martino J; Gomez E; Bilbao JL; Dueñas JC; Vázquez-Barquero A
Acta Neurochir (Wien); 2013 Jan; 155(1):41-50. PubMed ID: 23132374
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article.
Capelle L; Fontaine D; Mandonnet E; Taillandier L; Golmard JL; Bauchet L; Pallud J; Peruzzi P; Baron MH; Kujas M; Guyotat J; Guillevin R; Frenay M; Taillibert S; Colin P; Rigau V; Vandenbos F; Pinelli C; Duffau H;
J Neurosurg; 2013 Jun; 118(6):1157-68. PubMed ID: 23495881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
